Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02184104 · ClinicalTrials.gov registry record · NA
Caffeine Disposition After Inhalation
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02184104 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 24 participants.
The verdict
NCT02184104, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how fast caffeine gets into your body with a product called Aeroshot™. Aeroshot™ is a lipstick sized device that you slide open and then put your mouth over the opening and inhale. A fine powder containing 100 mg of caffeine is deposited on your tongue and the inside of your mouth. Caffeine will be absorbed through the membranes in your mouth or swallowed and then absorbed in your stomach. We will compare the absorption of caffeine after using the Aeroshot™ with the absorption after drinking an energy drink by taking 15 blood samples over 8 hours and measuring the caffeine levels in your blood. You will also be asked to fill out some scales to measure the effects you feel after the caffeine dose. We hypothesize that caffeine absorption after inhalation will be faster than after an energy drink.
Interventions
- DIETARY_SUPPLEMENT Caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02184104
The ClinicalTrials.gov registry entry for NCT02184104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Caffeine is the first listed.
NCT02184104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02184104 about?
NCT02184104 is a clinical study titled "Caffeine Disposition After Inhalation". The purpose of this study is to determine how fast caffeine gets into your body with a product called Aeroshot™. Aeroshot™ is a lipstick sized device that you slide open and then put your mouth over the opening and inhale. A fine powder containing 100 mg of caffeine is deposited on your tongue and t...
What is the current status of trial NCT02184104?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-07. Estimated completion is 2017-03-20.
What interventions are being tested in trial NCT02184104?
The interventions under investigation include: Caffeine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02184104?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.